Hydroxyurea Capsules

Product Description

Since last many years Saintroy Lifescience is leading manufacture,export and supplier of Hydroxyurea Capsules  from Surat, Gujarat, India. Hydroxyurea Capsules used in sickle-cell disease, chronic myelogenous leukemia, cervical cancer, and essential thrombocythemia. In sickle-cell disease it increases fetal hemoglobin and decreases the number of attacks.

Tags: Hydroxyurea Tablets Manufacturer ,Gefitinib Tablets exporter, Hydroxyurea Tablets supplier, Hydroxyurea Tablets,Hydroxyurea  potassium, whogmp approved Hydroxyurea Potassium tablets manufacturer and supplier, Hydroxyurea  Tablets distributor ,Hydroxyurea  Tablets drop shipper, Hydroxyurea Tablets 500 mg,Hydroxyurea Tablets 500 mg supplier, Hydroxyurea  Tablets 500 mg.

ISO/GMP/c-GMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturing facility in Gujarat, India.

Registration: Saintroy Lifescience is interested in registration of own brand or customer brands in ministry of health of clients country and we also provide the products samples, COA, COPP, ACTD or CTD Dossier, DMF, Manufacturing license, Free sale certificate and other required documents.

Export Country : Saintroy Lifescience export Hydroxyurea  Tablets To USA, Canada, Germany, Europe, France, Ghana, Nigeria, Kenya, Senegal, Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru, Chile, Somalia, Philippines,Myanmar, Maldives, Thailand, Singapore, Malaysia, Hong Kong, China, Zimbabwe,Togo, Burkina Faso, Niger, Guinea Bissau, Congo, Democratic of republic, IvoryCosta, Oman, Guatemala, Nicaragua, Salvador, Qatar, Costa Rica, Panama, Cuba,Colombia, Bolivia, Argentine, Algeria, Guyana, Morocco, Jordan, Bahrain, Iran,Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.